C

Cedar Crosse Research Center | Chicago, IL

Research site

(Unclaimed)

Location

800 S.Wells, Suite M15, Chicago, Illinois, United States of America

Site insights

Top conditions

Top treatments

Dapagliflozin

Empagliflozin

BMS-512148

PS433540

Ramipril

ABP-450

Metformin

Firibastat

Thiazolidinedione

Polypill

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 37 total trials

Locations recently updated

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Enrolling

Obesity

Drug: Placebo

Drug: survodutide

Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention

This Phase 2 Extension trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine...

Invitation-only

Migraine

Drug: ABP-450

Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

This Phase 2 trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine days per m...

Active, not recruiting

Migraine

Drug: ABP-450

Drug: Placebo